Medical researchers at the University of Hong Kong (HKU) have called for citywide action to track a drug-resistant superbug that made its presence felt in hospitals before the Covid-19 pandemic.
They suggested setting up a centralised reporting platform for all cases of Carbapenemase-producing Enterobacteriaceae – commonly referred to as CPE – to combat the surge.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
